We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+0.74%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.6B
AUM Growth
+$166M
Cap. Flow
+$350M
Cap. Flow %
0.98%
Top 10 Hldgs %
19.85%
Holding
1,363
New
118
Increased
473
Reduced
442
Closed
143

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$76.2M
2
SPGI icon
S&P Global
SPGI
+$73M
3
ADBE icon
Adobe
ADBE
+$62.1M
4
BMY icon
Bristol-Myers Squibb
BMY
+$56.5M
5
NVDA icon
NVIDIA
NVDA
+$52.5M

Top Sells

Rank Stock Value
1
BNY
Bank of New York Mellon
BNY
+$60.1M
2
CL icon
Colgate-Palmolive
CL
+$57.1M
3
CSCO icon
Cisco
CSCO
+$55.2M
4
GNRC icon
Generac Holdings
GNRC
+$44.8M
5
BABA icon
Alibaba
BABA
+$42.1M

Sector Composition

Rank Sector Weight
1 Technology 30.84%
2 Healthcare 17.62%
3 Consumer Discretionary 11.77%
4 Financials 10.38%
5 Industrials 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHT icon
1101
Chunghwa Telecom
CHT
$33.5B
$322K ﹤0.01%
8,200
EVC icon
1102
Entravision Communication
EVC
$1.02B
$322K ﹤0.01%
45,400
-5,500
-11% -$37.1K
PBH icon
1103
Prestige Consumer Healthcare
PBH
$2.47B
$320K ﹤0.01%
+5,700
New +$313K
HAE icon
1104
Haemonetics
HAE
$3.88B
$318K ﹤0.01%
+4,500
New +$284K
NRG icon
1105
NRG Energy
NRG
$26.2B
$318K ﹤0.01%
+7,800
New +$332K
MMSI icon
1106
Merit Medical Systems
MMSI
$4.82B
$316K ﹤0.01%
4,400
OTLK icon
1107
Outlook Therapeutics
OTLK
$187M
$315K ﹤0.01%
7,251
-8,364
-54% -$404K
NLY icon
1108
Annaly Capital Management
NLY
$17.3B
$306K ﹤0.01%
9,071
-23
-0.3% -$792
KDNY
1109
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$300K ﹤0.01%
+23,500
New +$309K
TALO icon
1110
Talos Energy
TALO
$2.38B
$288K ﹤0.01%
+20,900
New +$255K
VMW
1111
DELISTED
VMware, Inc
VMW
$287K ﹤0.01%
1,933
-62
-3% -$9.4K
LCUT icon
1112
Lifetime Brands
LCUT
$192M
$284K ﹤0.01%
+15,600
New +$261K
WWD icon
1113
Woodward
WWD
$23B
$283K ﹤0.01%
2,500
-10,700
-81% -$1.27M
IBRX icon
1114
ImmunityBio
IBRX
$7.15B
$281K ﹤0.01%
+28,800
New +$317K
THC icon
1115
Tenet Healthcare
THC
$22.2B
$279K ﹤0.01%
4,200
-11,900
-74% -$844K
CPT icon
1116
Camden Property Trust
CPT
$11.5B
$277K ﹤0.01%
1,880
-14,300
-88% -$2.1M
ARRY icon
1117
Array Technologies
ARRY
$740M
$275K ﹤0.01%
14,862
-12,386
-45% -$205K
FFIV icon
1118
F5
FFIV
$22B
$270K ﹤0.01%
1,359
PODD icon
1119
Insulet
PODD
$11.8B
$266K ﹤0.01%
937
+47
+5% +$13.4K
JNCE
1120
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$266K ﹤0.01%
35,800
+15,600
+77% +$96.6K
CTRA
1121
DELISTED
Coterra Energy
CTRA
$264K ﹤0.01%
12,133
-122,336
-91% -$2.1M
AVA icon
1122
Avista
AVA
$3.43B
$262K ﹤0.01%
6,700
WHF icon
1123
WhiteHorse Finance
WHF
$138M
$260K ﹤0.01%
17,100
TTD icon
1124
Trade Desk
TTD
$8.97B
$259K ﹤0.01%
3,684
-3,000
-45% -$232K
WPC icon
1125
W.P. Carey
WPC
$16.6B
$252K ﹤0.01%
3,527
+75
+2% +$5.71K

Similar funds

Axa's Q3 2021 Portfolio in Review

As of Q3 2021, Axa held 1,363 positions worth $35.6B, up 0.47% from $35.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Axa's Q3 2021 filing shows 118 new, 473 increased, 442 reduced and 143 closed positions. Its largest new stake was GXO Logistics: 575,960 shares worth $45.2M. The largest sale was Bank of New York Mellon, an estimated $60.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2021 buy was GXO Logistics: 575,960 shares worth $45.2M.
  • Axa added most to AT&T in Q3 2021, an estimated $76.2M increase.
  • Axa's biggest Q3 2021 reduction was Bank of New York Mellon, cutting an estimated $60.1M.
  • Axa fully exited Proofpoint, Inc. in Q3 2021, selling an estimated $35.3M.
  • Axa's ten largest holdings make up 20% of its $35.6B portfolio in Q3 2021.
  • Axa opened 118 new positions and closed 143 in Q3 2021.
  • Axa's portfolio value rose 0.47% quarter-over-quarter to $35.6B.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.